Hello, my wonderful readers! Ahmedabad is home to the multinational pharmaceutical company Intas Pharmaceuticals Limited. It manufactures generic therapeutic drugs and performs clinical research and manufacturing under contract. It has 18 manufacturing facilities, with 15 of them in India and the remaining seven in the UK and Mexico. 31% of the company’s revenue in the 2019 fiscal year came from India, while 69% came from foreign markets. FFR Intas entire details are given in this blog! You can log on to FFR Intas with newffr.intaspharma.co.in/intasffr!
What is Intas Pharmaceuticals Limited?
Hasmukh Chudgar, a Jain pharmacist, founded the business in 1977, and it was incorporated in 1985. In 2013, ChrysCapital bought a 16.14% stake in the business; in 2015, it sold 10.13% of that stake to Temasek Holdings in Singapore; and in 2017, it further diluted its stake by selling 3.01% of it to Capital International. ChrysCapital did, however, repurchase Capital International’s stake by May 2020. The Chudgar family currently holds 83.85% of the company’s shares, while Temasek Holdings and ChrysCapital each hold 10.13% and 6.02%, respectively.
The company had 19 manufacturing facilities operating as of March 2021, 13 of which were in India, 5 in the UK, and 1 in Mexico. In Bavla, close to Ahmedabad, the company built a new manufacturing facility that could produce and export more than 1 billion solid dosages and 5 million injectables.
A Brief History of the FFR Intas
FFR Intas is a major global drug definition advancement, manufacturing, and marketing company with a global presence. FFR Intas is committed to investigating underappreciated clinical and cultural requirements through a global drug esteem chain.
- FFR Intas has established an auxiliary organization known as Accord Healthcare to conduct business in the global business sectors. Intas has grown year after year through organic growth and acquisition, expanding its product portfolio and business activities.
- Intas’ outstanding performance in North American and European projects has helped to establish the company as a global brand name.
- All of FFR Intas’ products and services demonstrate the company’s strict quality standards, which are evident in everything the company does.
- Intas’ fragment-driven pipeline and strong internal advancement skills enable it to compete with some of the industry’s most spectacular portfolios. The company is now concentrating its efforts on more difficult-to-approve upgrades, such as Biosimilars and New Chemical Entities, to raise the global level of medical service excellence as soon as possible.
- FFR Intas places a high value on its employees’ decision-making abilities. As a result, Intas intends to acquire and retain the best possible competencies across the organization to maximize the utilization of its various business sectors.
Biologics Unit (formerly Intas Biopharmaceuticals)
Hematologist Urmish Chudgar established Intas Biopharmaceuticals in 2006 as an independent biotechnology division of Intas Pharmaceuticals. The subsidiary and the parent company, Intas Pharmaceuticals Limited, merged in 2012–2013. This division develops and produces biosimilar products using monoclonal antibodies and recombinant DNA.
The company underwent an EU-GMP (Good Manufacturing Practices) audit in December 2006 to request authorization for a clinical trial of its biosimilar Filgrastim in Europe. In April 2007, the company received certification as EU-GMP compliant, making it the first company in India to do so. The business introduced Filgrastim, its first biosimilar product, in Europe in 2015 to treat patients with advanced HIV infection and immune system disorders like neutropenia.
The MCC South Africa has also approved the company’s manufacturing facility and products, the Gulf Cooperation Council (GCC), Syria, Yemen, Belarus, and several other national health authorities and being EU-GMP certified.
Import Alert
On June 1, Intas Pharmaceuticals received notification from the US Food and Drug Administration (FDA) that the company’s manufacturing facility in Ahmedabad—Special Economic Zone (Pharmez), near Matoda—had been placed on ‘Import Alert.’
Import Alerts notify the FDA’s field staff and the general public that the federal agency has sufficient evidence to allow for the detention of products that appear to violate the FDA’s laws and regulations without physical examination. Potentially illegal products ar from being distributed in the United States.
The US FDA
The US FDA inspected this facility between November and December 2022, and the company received an 11-observation Form 483, with the majority of the observations centered on data integrity and quality compliance. “…We discovered a truck full of transparent plastic bags containing shredded documents and black plastic bags mostly containing documents torn randomly into pieces by hand mixed with other scrap materials,” according to the FDA’s compliance record. Following receipt of the Form 483 observations, Intas claims it made an immediate and voluntary decision to temporarily halt production and distribution of products manufactured at the SEZ facility designated for the United States.
Following the completion of necessary testing and verification, the US FDA has permitted Intas to continue supplying 24 critical products in short supply in the US. According to the USFDA list, critical medications excluded from use include injectable products from therapeutic fields like vitamins, oncology, bacterial infections, cardiology, sedation, tablet products used in Neurotherapy, kidney stone diseases, cancer treatment, hormonal complications, and heart issues.
Written Statement
Intas said in a written statement to Forbes India that patient safety would always be the company’s top priority. Intas has conducted a baseline evaluation of its quality management systems and personnel and is putting corrective measures into place as part of that commitment, working cooperatively with external cGMP experts. They are also collaborating with the FDA on a plan to restart manufacturing at the SEZ for the US market, starting with a few essential oncology products. They are completely committed to upholding its tradition of providing high-quality medications. The US market accounts for 18% of the company’s total revenue, which as of March 2022, is estimated to be Rs18,400 crore, and its domestic business generates 32% of the total.
Indian Pharmaceutical
The problem extends beyond Intas and involves several large Indian pharmaceutical companies involved in a regulatory shootout with the US FDA. Why do they keep happening? “Due to increased competition and rising buyer bargaining power, costs are rising, but prices are falling. Companies have been trying to increase the volume of products to deal with the drop in value, which makes managing regulatory compliance even more difficult, according to Vishal Manchanda, senior vice president of institutional research, at Systematix Group. A portion of the Indian pharmaceutical industry speculates that US Big Pharma lobbying against Indian generic manufacturers may cause heightened regulatory scrutiny.
newffr.intaspharma.com/intasffr how to log in?
It is simple and safe to use newffr.intaspharma! To log in, enter your newffr.intaspharma username and password into the appropriate fields on the login page. If you forget your username or password, you can recover them by clicking the forgot username or reset password links on the login page.
After entering your newffr.intaspharma login information, click the “Log In” button to gain access to newffr.intaspharma and begin managing your account. For added security, newffr.intaspharma may request that you enter a one-time code sent to your registered mobile phone number.
newffr.intaspharma Important Links
| FFORCE Login – Intas Pharma | https://newffr.intaspharma.com/IntasFFR |
| FForce EOBS – Intas Pharma | https://newffr.intaspharma.com/OnlineEOBS/frmEOBSUpload.aspx |
| FFR Login | https://pharmedltd.in/PLBffr |
| Login | https://intasintraweb.intaspharma.com |
| Newffr.intaspharma.com Catalogs | Daily Catalog | https://daily-catalog.com/newffr.intaspharma.com |
Intas is a global pharmaceutical company. It is fully integrated and focuses on new product research and development. “newffr.intaspharma” is their new online platform that allows customers to learn about new Intas products, services, and medicines.
Entering your username and password into the corresponding fields on the login page will allow you to access newffr.intaspharma.
Other Domain Links
- ffr intas login
- newffr intaspharma
- intas ffr login
- Newffr.intaspharma
- Newffr
- newffr.intaspharma.com/intasffr
- new intas ffr
- ffr login intas
- newffr.intaspharma.com/intas ffr
- newffr.intaspharma.co.in/intasffr
Common Questions
What is the process for logging into FFr Intas system?
The first step in logging into the FFr Intas pharma system is to launch a web browser. Then go to the login page. Enter your username and password that were provided to you by Intas Pharma. Once logged in, users can access the Ffr system.
How can I reset my FFr Intas pharma login credentials for Intas Pharma?
You can get assistance from Intas Pharma’s IT department to reset your FFr Intas pharma login credentials by contacting them.
What security measures are in place for the FFr Intas pharma login system?
Many security precautions are in place for the FFr Intas pharma login system. They are two-factor authentication, strict password requirements, and recurring security audits. A safe server has the system additionally hosted on. It has modern firewalls and encryption protocols.
Is there a mobile app available for the FFr Intas pharma login system?
No, there is not a mobile app for the FFr Intas pharma login system right now.
Is newffr.intaspharma Secure?
Yes, newffr.intaspharma is a secure platform with additional security features, such as authentication codes sent to registered mobile phone numbers.
To ensure your safety and privacy, newffr.intaspharma recommends that you safeguard your newffr.intaspharma login credentials and update them regularly.
Forgotten Username and Password Link
On the newffr.intaspharma login page, there are helpful links like “forgot username” and “reset password.” They can help you recover your username or password if you forget them.
Authentication Code
You might also be required to enter a one-time code sent to your registered mobile phone number by newffr.intaspharma. It is an additional security measure.
Customer Support
Customer service for newffr.intaspharma is available around-the-clock to assist you if you have any questions or concerns about the website.
Conclusion
This blog post has provided you with a better understanding of newffr.intaspharma login and the important login links. You can easily and securely access newffr.intaspharma and manage your FFr Intas account by following these simple steps.
Read similar blogs by clicking here.
